Abstract
Efficiently scouting the chemical space is one of the major challenges for lead discovery for drug development. In recent times some shifts have been made away from HTS and combinatorial chemistry to more focused approaches. Combinatorial chemistry was the starting point for the development of synthesis concepts that were intended to cover and explore the chemical space without having to prepare every individual compound. In this review, these lead finding approaches will be discussed comparing virtual and synthesized libraries. In addition we discuss the concepts and relationships of evolutionary libraries using genetic algorithms and dynamic combinatorial chemistries, as well as templated fragment ligation concepts. Taking a more abstract view of all approaches, the concepts may loop back into Combinatorial Chemistry allowing a more educated choice of building blocks and chemistries.
Keywords: pharmacological screening, genomic, high-throughput identification, drug discovery, mass spectrometry, oligonucleotides, combinatorial synthesis, mrna, dynamic combinatorial library, thermodynamics
Current Drug Discovery Technologies
Title: Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?
Volume: 2 Issue: 1
Author(s): Hans Peter Nestler
Affiliation:
Keywords: pharmacological screening, genomic, high-throughput identification, drug discovery, mass spectrometry, oligonucleotides, combinatorial synthesis, mrna, dynamic combinatorial library, thermodynamics
Abstract: Efficiently scouting the chemical space is one of the major challenges for lead discovery for drug development. In recent times some shifts have been made away from HTS and combinatorial chemistry to more focused approaches. Combinatorial chemistry was the starting point for the development of synthesis concepts that were intended to cover and explore the chemical space without having to prepare every individual compound. In this review, these lead finding approaches will be discussed comparing virtual and synthesized libraries. In addition we discuss the concepts and relationships of evolutionary libraries using genetic algorithms and dynamic combinatorial chemistries, as well as templated fragment ligation concepts. Taking a more abstract view of all approaches, the concepts may loop back into Combinatorial Chemistry allowing a more educated choice of building blocks and chemistries.
Export Options
About this article
Cite this article as:
Nestler Peter Hans, Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?, Current Drug Discovery Technologies 2005; 2 (1) . https://dx.doi.org/10.2174/1570163053175484
DOI https://dx.doi.org/10.2174/1570163053175484 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Complete Uterine Rupture a Stigma for Modern Obstetrics: An Observational Study
Current Women`s Health Reviews Emerging Role of CD44 Receptor as a Potential Target in Disease Diagnosis: A Patent Review
Recent Patents on Inflammation & Allergy Drug Discovery Apoptosis in Atherosclerosis: Virtue or Vice
Current Cardiology Reviews Nitric Oxide and Dietary Factors: Part I Nitric Oxide Synthesis and Action
Vascular Disease Prevention (Discontinued) Anticoagulant Therapy for Acute Lung Injury or Pneumonia
Current Drug Targets Biochemical Aspects of Nitric Oxide
Current Pharmaceutical Design Rho-Kinase and RGS-Containing RhoGEFs as Molecular Targets for the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Central Oxytocinergic Neurotransmission: A Drug Target for the Therapy of Psychogenic Erectile Dysfunction
Current Drug Targets Kidney Diseases and Chemokines
Current Drug Targets Aromatherapy and the Central Nerve System (CNS): Therapeutic Mechanism and its Associated Genes
Current Drug Targets Patent Selections
Recent Patents on Regenerative Medicine Current Evidence on the Evaluation and Management of Fever Without a Source in Infants Aged 0-90 Days: A Review
Reviews on Recent Clinical Trials Lessons Learned from HIV Vaccine Clinical Efficacy Trials
Current HIV Research Potential Use of Protease Inhibitors as Vaginal and Colorectal Microbicides
Current HIV Research Herb-Drug Interactions: An Evidence Based Approach
Current Medicinal Chemistry Revising Skin Cancers by Means of Epigenetic Markers
Recent Patents on Biomarkers Safety of Drug Eluting Stents: Current Concerns and Controversies
Current Drug Safety Synthesis and Biological Activity of New Tricyclic Purine Derivatives Obtained by Intramolecular N-7 Alkylation
Letters in Drug Design & Discovery Amino Thiols, Detoxification and Oxidative Stress in Pre-Eclampsia and Other Disorders of Pregnancy
Current Pharmaceutical Design Pomegranate, its Components, and Modern Deliverable Formulations as Potential Botanicals in the Prevention and Treatment of Various Cancers
Current Drug Delivery